NASDAQ · ALC
Healthcare · Medical - Instruments & Supplies
$72.01
Down-$0.22 (-0.30%)
Updated Aug 31, 2026, 12:56 PM
SID Score
5.9/10
Composite research score
Smart Money
47/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
ALC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning ALC.
ALC research
Company profile and research snapshot.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | BERENBERG | Buy | — |
| Jul 12, 2026 | DAY BY DAY | Sell | — |
| Jul 9, 2026 | EQUITA SIM | Buy | — |
| Jun 24, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 4, 2026 | NEEDHAM & COMPANY INC. | Buy | — |
No generated briefing is available yet.
Yahoo · Aug 24, 2026
Sustainable Growth Advisers (SGA), an investment management company, released its second-quarter 2026 investor letter for its “Global Growth Strategy.” The letter can be downloaded here. The SGA Global Growth Portfolio returned 7.4% gross and 7.2% net, compared with 14.9% for the MSCI ACWI and 19.8% for the MSCI ACWI Growth Index. Momentum leadership and enthusiasm around […]
Yahoo · Aug 20, 2026
Glaukos' iDose TR momentum and Epioxa launch are driving record growth, higher 2026 guidance and a broader ophthalmology platform.
Yahoo · Aug 19, 2026
Pershing Square Holdings, an investment holding company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. Pershing Square is an alternative asset manager that primarily manages capital in publicly traded investment vehicles, with 98% of its capital structure dedicated to such assets, including Howard Hughes Holdings. This capital […]
Yahoo · Aug 17, 2026
Net sales grew 7% to $2.8 billion as surgical and vision care divisions both expanded.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ALC.
